A multicomponent nanosystem for capturing circulating tumor cells from cancer patients with PD-L1 as an immunotherapy oncotarget

DOI: 10.1039/d4tb01360c Publication Date: 2024-09-18T07:18:03Z
ABSTRACT
OncoDiscover® is a novel platform for the capture of rare circulating tumor cells from cancer patients in the presence of the PD-L1 oncotarget. It is being used routinely in the clinic for prognosis to improve the overall survival of cancer patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (42)
CITATIONS (0)